ClinicalTrials.gov record
Completed Phase 3 Interventional

Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

ClinicalTrials.gov ID: NCT02570490

Public ClinicalTrials.gov record NCT02570490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Oral Sodium Fusidate (CEM-102) Compared to Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections

Study identification

NCT ID
NCT02570490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arrevus Inc.
Industry
Enrollment
716 participants

Conditions and interventions

Interventions

  • linezolid Drug
  • sodium fusidate Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2015
Primary completion
Oct 31, 2016
Completion
Oct 31, 2016
Last update posted
Apr 18, 2019

2015 – 2016

United States locations

U.S. sites
60
U.S. states
17
U.S. cities
49
Facility City State ZIP Site status
Not listed Anaheim California 92804
Not listed Bakersfield California 93301
Not listed Buena Park California 90620
Not listed Fountain Valley California 92708
Not listed La Mesa California 91942
Not listed La Palma California 90623
Not listed Long Beach California 90813
Not listed Los Angeles California 90020
Not listed Modesto California 95350
Not listed National City California 91950
Not listed Oceanside California 92056
Not listed Riverside California 92506
Not listed San Diego California 89109
Not listed San Diego California 91911
Not listed San Diego California 91942
Not listed San Diego California 92114
Not listed San Diego California 92120
Not listed San Dimas California 91773
Not listed Stockton California 95204
Not listed Sylmar California 91342
Not listed DeBary Florida 32713
Not listed DeLand Florida 32720
Not listed Doral Florida 33126
Not listed Doral Florida 33166
Not listed Hollywood Florida 33021
Not listed Miami Florida 33015
Not listed Miami Florida 33126
Not listed Miami Florida 33144
Not listed Miami Florida 33155
Not listed Miami Florida 33175
Not listed Miami Lakes Florida 33014
Not listed Orlando Florida 32806
Not listed South Miami Florida 33143
Not listed West Palm Beach Florida 33401
Not listed Augusta Georgia 30909
Not listed Columbus Georgia 31904
Not listed Savannah Georgia 31401
Not listed Baker Louisiana 70714
Not listed Eunice Louisiana 70535
Not listed Lutherville Maryland 21093
Not listed Boston Massachusetts 02111
Not listed Detroit Michigan 48202
Not listed Royal Oak Michigan 48703
Not listed St Louis Missouri 63128
Not listed Butte Montana 59701
Not listed Lincoln Nebraska 68510
Not listed Somers Point New Jersey 08244
Not listed Teaneck New Jersey 07666
Not listed Cincinnati Ohio 45219
Not listed Philadelphia Pennsylvania 19103
Not listed Lancaster South Carolina 29720
Not listed Summerville South Carolina 29485
Not listed Rapid City South Dakota 57702
Not listed Jackson Tennessee 38305
Not listed Gonzales Texas 78629
Not listed Houston Texas 77011
Not listed Houston Texas 77084
Not listed Houston Texas 77093
Not listed San Antonio Texas 78229
Not listed Splendora Texas 77372

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02570490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2019 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02570490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →